Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析

◆英語タイトル:Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0509
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sumitomo Seika Chemicals Co Ltd (4008) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sumitomo Seika Chemicals Company Limited (SSC) manufactures chemicals, polymer products, gas products, engineering and chemical equipment. The company offers a wide range of products that include super absorbent polymers, electronic gases, medical gases, functional chemicals, fine chemicals, oxygen gas generators. Its industrial chemicals include sulfur compounds, chlorinated pyridines, chlorinated compounds, and others. The company also offers gas generators with gas purification and separation systems, and equipments for electronics industry. SSC’s products are used in various industries such as electronics, pharmaceuticals, consumer goods, agriculture, automobile, and manufacturing. It has operations in Japan, Singapore, Taiwan, the US, Belgium, China and South Korea. SSC is headquartered in Osaka, Japan.

Sumitomo Seika Chemicals Co Ltd Key Recent Developments

Aug 06,2018: Sumitomo Seika Chemicals announces consolidated financial Results for the Three Months Ended June 30, 2018
May 15,2018: Sumitomo Seika Chemicals Announces Consolidated Financial Results For Fiscal Year 2017
Feb 09,2018: Sumitomo Seika Chemicals Announces Consolidated Financial Results For Nine Months Ended December 31, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sumitomo Seika Chemicals Co Ltd – Key Facts
Sumitomo Seika Chemicals Co Ltd – Key Employees
Sumitomo Seika Chemicals Co Ltd – Major Products and Services
Sumitomo Seika Chemicals Co Ltd – History
Sumitomo Seika Chemicals Co Ltd – Company Statement
Sumitomo Seika Chemicals Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sumitomo Seika Chemicals Co Ltd – Business Description
Business Segment: Energy & Functional Materials
Overview
Performance
Business Segment: Health & Crop Sciences
Overview
Performance
Business Segment: IT-related Chemicals
Overview
Performance
Business Segment: Others
Overview
Performance
Business Segment: Petrochemicals & Plastics
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Sumitomo Seika Chemicals Co Ltd – Corporate Strategy
Sumitomo Seika Chemicals Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Sumitomo Seika Chemicals Co Ltd – Strengths
Sumitomo Seika Chemicals Co Ltd – Weaknesses
Sumitomo Seika Chemicals Co Ltd – Opportunities
Sumitomo Seika Chemicals Co Ltd – Threats
Sumitomo Seika Chemicals Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Aug 06, 2018: Sumitomo Seika Chemicals announces consolidated financial Results for the Three Months Ended June 30, 2018
May 15, 2018: Sumitomo Seika Chemicals Announces Consolidated Financial Results For Fiscal Year 2017
Feb 09, 2018: Sumitomo Seika Chemicals Announces Consolidated Financial Results For Nine Months Ended December 31, 2017
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sumitomo Seika Chemicals Co Ltd, Key Facts
Sumitomo Seika Chemicals Co Ltd, Key Employees
Sumitomo Seika Chemicals Co Ltd, Major Products and Services
Sumitomo Seika Chemicals Co Ltd, History
Sumitomo Seika Chemicals Co Ltd, Other Locations
Sumitomo Seika Chemicals Co Ltd, Subsidiaries
Sumitomo Seika Chemicals Co Ltd, Key Competitors
Sumitomo Seika Chemicals Co Ltd, Ratios based on current share price
Sumitomo Seika Chemicals Co Ltd, Annual Ratios
Sumitomo Seika Chemicals Co Ltd, Annual Ratios (Cont...1)
Sumitomo Seika Chemicals Co Ltd, Annual Ratios (Cont...2)
Sumitomo Seika Chemicals Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sumitomo Seika Chemicals Co Ltd, Performance Chart (2015 - 2019)
Sumitomo Seika Chemicals Co Ltd, Ratio Charts

★海外企業調査レポート[Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • Uni-Select Inc.:企業のM&A・事業提携・投資動向
    Uni-Select Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uni-Select Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Bharat Heavy Electricals Ltd (BHEL):電力:M&Aディール及び事業提携情報
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • Stanford University-製薬・医療分野:企業M&A・提携分析
    Summary Stanford University is an educational and research organization that provides graduate and undergraduate programs. The organization’s services include education and research facilities. It provides research facilities through its research laboratories and centers. Stanford University include …
  • Hudson’s Bay Company (HBC):企業の財務・戦略的SWOT分析
    Hudson's Bay Company (HBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Atlas Energy Group LLC:企業の戦略・SWOT・財務情報
    Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report Summary Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報
    Summary Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervou …
  • OncoSil Medical Ltd (OSL):企業の財務・戦略的SWOT分析
    Summary OncoSil Medical Ltd (OncoSil), is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous …
  • Erasmus MC-製薬・医療分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • LIC of India:企業の戦略・SWOT・財務情報
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • DNO ASA (DNO):石油・ガス:M&Aディール及び事業提携情報
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Santen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd, is a pharmaceutical company that develops, manufactures and markets ophthalmic products. The company offers products in therapeutic areas of retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis c …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • Prinzhorn Holding Gmbh:企業の戦略・SWOT・財務分析
    Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Seiko Epson Corp (6724):企業の財務・戦略的SWOT分析
    Seiko Epson Corp (6724) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Spark Therapeutics Inc (ONCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆